Products / Services
  • Products / Services
  • Companies
  • Buy Leads
Post Buy Requirement

Durvalumab Injection, API Form : Liquid

Listing ID #6529896

  • API FormLiquid
  • TreatmentCancer
  • DosageAs per Doctor's Prescription
  • StorageCool and Dry Place
  • Best Before36 Months from Manufacturing
  • Supply Type Supplier
  • Preferred Buyer Location All over the world
Send Enquiry

Company Information

  • Member Since 2 Years
  • Nature of Business Exporter
  • GST No. 07ABEFM6994Q2Z7

Ask for more detail from the seller

Contact Supplier

Product Details no_img_icon

A drug that binds to the protein PD-L1 to help immune cells kill cancer cells better and is used to treat different types of cancer. Durvalumab is used alone or with other drugs to treat adults with certain types of extensive-stage small cell lung cancer or stage III non-small cell lung cancer. It is also being studied in the treatment of other types of cancer. Durvalumab may block PD-L1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Imfinzi. US Brand Name(s): Imfinzi. FDA Approved: Yes

 

Durvalumab is approved to treat:

  • Non-small cell lung cancer (NSCLC). It is used in adults with stage III NSCLC that cannot be removed by surgery and did not get worse after platinum chemotherapy and radiation therapy.
  • Small cell lung cancer in adults. It is used with etoposide phosphate and either carboplatin or cisplatin as the first treatment in adults with extensive-stage cancer.
  • Durvalumab is also being studied in the treatment of other types of cancer.

 

The US Food and Drug Administration (FDA) has approved durvalumab for certain types of bladder and lung cancer:

  • Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
  • Adults with unresectable, Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
  • In combination with etoposide and either carboplatin or cisplatin, as first-line treatment for adults with extensive-stage small cell lung cancer.


Company Details close-icon

Established in 2016, Medicant Healthcare has secured a noticeable position among the Exporter and service providers of good quality Pharmaceutical Medicines and Cancer Drugs. Our drugs are designed following the FDA norms under the strict supervision of qualified experts. Our product range comprises Ulcerative Colitis, Uterus Cancer, Thyroid Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Kidney Cancer, Gastric Cancer, Immunology, and Colorectal Cancer. Known for their fast and long-lasting results, these drugs are rather demanded around the world.

For the secure and hygienic design of the available drugs, we have established a roomy infrastructure, which is further segregated into numerous departments. The departments are capable of advanced machines, which are upgraded according to the present market demands.

A well-maintained warehouse makes sure useful storage of the offered products. According to the vast and trustworthy logistic partners, we bring our products to the customer’s end within the set time frame. Moreover, our drugs are made available at an affordable market cost.

Our revered mentors, Mr. Akhilesh Chaudhary, motivate the team with their rich industry knowledge and experience. The prime focus is on offering a smooth and pressure-free work setting for the employees and has assisted them to give their best. Additionally, they have enabled the company in gaining a strong market stand among the manufacturers and suppliers of excellent quality pharmaceutical medicines and cancer drugs.

  • Nature of Business Exporter / Service Provider / Supplier
  • Number of Employees Below 20
  • Year of Establishment 2016
Tell us your Buy Requirement to Get Instant Response
Tell us what you need?

By clicking Get Quotes Now, I accept the T&C and Privacy Policy.

Looking for Durvalumab Injection?

Quantity
Seller Contact Details
Waiting for permission
To search by voice, go to your browser settings and allow access to microphone

Allow microphone access to search with voice
Durvalumab Injection, API Form : Liquid at Best Price in delhi - ID: 6529896
Products / Services
  • Products / Services
  • Companies
  • Buy Leads
Post Buy Requirement

Durvalumab Injection, API Form : Liquid

Listing ID #6529896

  • API FormLiquid
  • TreatmentCancer
  • DosageAs per Doctor's Prescription
  • StorageCool and Dry Place
  • Best Before36 Months from Manufacturing
  • Supply Type Supplier
  • Preferred Buyer Location All over the world
Send Enquiry

Company Information

  • Member Since 2 Years
  • Nature of Business Exporter
  • GST No. 07ABEFM6994Q2Z7

Ask for more detail from the seller

Contact Supplier

Product Details no_img_icon

A drug that binds to the protein PD-L1 to help immune cells kill cancer cells better and is used to treat different types of cancer. Durvalumab is used alone or with other drugs to treat adults with certain types of extensive-stage small cell lung cancer or stage III non-small cell lung cancer. It is also being studied in the treatment of other types of cancer. Durvalumab may block PD-L1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Imfinzi. US Brand Name(s): Imfinzi. FDA Approved: Yes

 

Durvalumab is approved to treat:

  • Non-small cell lung cancer (NSCLC). It is used in adults with stage III NSCLC that cannot be removed by surgery and did not get worse after platinum chemotherapy and radiation therapy.
  • Small cell lung cancer in adults. It is used with etoposide phosphate and either carboplatin or cisplatin as the first treatment in adults with extensive-stage cancer.
  • Durvalumab is also being studied in the treatment of other types of cancer.

 

The US Food and Drug Administration (FDA) has approved durvalumab for certain types of bladder and lung cancer:

  • Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
  • Adults with unresectable, Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
  • In combination with etoposide and either carboplatin or cisplatin, as first-line treatment for adults with extensive-stage small cell lung cancer.


Company Details close-icon

Established in 2016, Medicant Healthcare has secured a noticeable position among the Exporter and service providers of good quality Pharmaceutical Medicines and Cancer Drugs. Our drugs are designed following the FDA norms under the strict supervision of qualified experts. Our product range comprises Ulcerative Colitis, Uterus Cancer, Thyroid Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Kidney Cancer, Gastric Cancer, Immunology, and Colorectal Cancer. Known for their fast and long-lasting results, these drugs are rather demanded around the world.

For the secure and hygienic design of the available drugs, we have established a roomy infrastructure, which is further segregated into numerous departments. The departments are capable of advanced machines, which are upgraded according to the present market demands.

A well-maintained warehouse makes sure useful storage of the offered products. According to the vast and trustworthy logistic partners, we bring our products to the customer’s end within the set time frame. Moreover, our drugs are made available at an affordable market cost.

Our revered mentors, Mr. Akhilesh Chaudhary, motivate the team with their rich industry knowledge and experience. The prime focus is on offering a smooth and pressure-free work setting for the employees and has assisted them to give their best. Additionally, they have enabled the company in gaining a strong market stand among the manufacturers and suppliers of excellent quality pharmaceutical medicines and cancer drugs.

  • Nature of Business Exporter / Service Provider / Supplier
  • Number of Employees Below 20
  • Year of Establishment 2016
Tell us your Buy Requirement to Get Instant Response
Tell us what you need?

By clicking Get Quotes Now, I accept the T&C and Privacy Policy.

Looking for Durvalumab Injection?

Quantity
Seller Contact Details
Waiting for permission
To search by voice, go to your browser settings and allow access to microphone

Allow microphone access to search with voice